Rosacea Marketed and Pipeline Drugs Assessment, Clinical Trials and Competitive Landscape
The Rosacea pipeline drugs market research report includes an assessment of the disease epidemiology, leading marketed products, and late-to-mid-stage pipeline products with Phase Transition Success Rate (PTSR), and Likelihood of Approval (LoA) for rosacea. The report also analyzes the clinical and commercial landscapes of rosacea, as well as an assessment of deals, future market catalysts, key market players, and the future competitive environment.
Rosacea is a chronic relapsing inflammatory skin disease characterized by immune dysfunction and neurovascular dysregulation. Though its pathophysiologic connections remain to be defined, there are numerous studies showing association of rosacea with chronic inflammatory conditions including inflammatory cytokines and metabolic, immune, and endocrine changes.
Which are the key regions in the Rosacea pipeline drugs market?
The key regions in the Rosacea pipeline drugs market are Asia-Pacific, Europe, Middle Eat & Africa, South & Central America. Single-country trials dominated in rosacea globally over the past 10 years, with highest number of trials registered in North America.
Rosacea pipeline drugs market, by regions
For more region insights, download a free report sample
Which are the key development stages in the Rosacea pipeline drugs market?
The key development stages in the Rosacea pipeline drugs market are phase II, phase III, phase I, and preclinical. Preclinical stage has the highest share in the Rosacea pipeline drugs market.
Rosacea pipeline drugs market, by development stage
For more development stage insights, download a free report sample
Which are the key molecule types in the Rosacea pipeline drugs market?
The key molecule types in the Rosacea pipeline drugs market are small molecule, and biologic. The majority of drugs with a known molecule type in development for the treatment of rosacea are small molecules.
Rosacea pipeline drugs market, by molecule types
For more molecule type insights, download a free report sample
Which are the key MoA in the Rosacea pipeline drugs market?
The key MoA in the Rosacea pipeline drugs market are genes, nucleic acid, & related components inhibitor, enzyme inhibitor, receptor antagonist, receptor inhibitor, cells and cells organelle disrupter, protein and peptide inhibitor. Most of the molecules undergoing development for rosacea with a known mechanism of action are inhibitors of genes, nucleic acids, and related components.
Rosacea pipeline drugs market, by MoA
For more MoA insights, download a free report sample
Which are the key RoA in the Rosacea pipeline drugs market?
The key RoA in the Rosacea pipeline drugs market are topical, oral, injection, and inhalational. Inhalational has the highest share in the Rosacea pipeline drugs market.
Rosacea pipeline drugs market, by RoA
For more RoA insights, download a free report sample
Which are the key sponsors in the Rosacea pipeline drugs market?
The key sponsors in the Rosacea pipeline drugs market are Galderma SA, Allergan Ltd, Cutanea Life Sciences Inc, So-Gel Technologies Inc, Foamix Pharmaceuticals Ltd, Amorepacific Corp, Padagis LLC, and others.
Rosacea pipeline drugs market, by sponsors
To know more about sponsors, download a free report sample
Market report overview
| Key regions | Asia-Pacific, Europe, Middle Eat & Africa, South & Central America |
| Key development stages | Phase II, Phase III, Phase I, And Preclinical |
| Key molecule types | Small Molecule, and Biologic |
| Genes, Nucleic Acid, & Related Components Inhibitor, Enzyme Inhibitor, Receptor Antagonist, Receptor Inhibitor, Cells and Cells Organelle Disrupter, Protein and Peptide Inhibitor | |
| Key RoA | Topical, Oral, Injection, and Inhalational |
| Key sponsors | Galderma SA, Allergan Ltd, Cutanea Life Sciences Inc, So-Gel Technologies Inc, Foamix Pharmaceuticals Ltd, Amorepacific Corp, and Padagis LLC |
Scope
GlobalData’s Rosacea: Competitive Landscape in 2022 combines data from the Pharma Intelligence Center with in-house analyst expertise to provide a competitive assessment of the disease marketplace.
Components of the report include:
- Disease Landscape
- Disease Overview
- Epidemiology Overview
- Treatment Overview
- Marketed Products Assessment
- Breakdown by Mechanism of Action, Molecule Type and Route of Administration
- Pipeline Assessment
- Breakdown by Development Stage, Mechanism of Action, Molecule Type, Route of Administration
- Late-to-mid-stage Pipeline Drugs
- Phase Transition Success Rate and Likelihood of Approval
- Clinical Trials Assessment
- Breakdown of Trials by Phase, Status, Virtual Components, Sponsors, Geography, and Endpoint Status
- Enrolment Analytics, Site Analytics, Feasibility Analysis
- Deals Landscape
- Mergers, Acquisitions, and Strategic Alliances by Region
- Overview of Recent Deals
- Commercial Assessment
- Key Market Players
- Future Market Catalysts
Reasons to Buy
- Develop and design your in-licensing and out-licensing strategies through a review of pipeline products and technologies, and by identifying the companies with the most robust pipeline.
- Develop business strategies by understanding the trends shaping and driving the Rosacea market.
- Drive revenues by understanding the key trends, innovative products and technologies, market segments, and companies likely to impact the global Rosacea market in the future.
- Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
- Identify emerging players with potentially strong product portfolios and create effective counter-strategies to gain a competitive advantage.
- Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments, and strategic partnerships.
Table of Contents
Frequently Asked Questions
The key regions in the Rosacea pipeline drugs market are Asia-Pacific, Europe, Middle Eat & Africa, South & Central America. Single-country trials dominated in rosacea globally over the past 10 years, with highest number of trials registered in North America.
The key development stage in the Rosacea pipeline drugs market are phase II, phase III, phase I, and preclinical. Preclinical stage has the highest share in the Rosacea pipeline drugs market.
The key molecule types in the Rosacea pipeline drugs market are small molecule, and biologic. The majority of drugs with a known molecule type in development for the treatment of rosacea are small molecules.
The key MoA in the Rosacea pipeline drugs market are genes, nucleic acid, & related components inhibitor, enzyme inhibitor, receptor antagonist, receptor inhibitor, cells and cells organelle disrupter, protein and peptide inhibitor. Most of the molecules undergoing development for rosacea with a known mechanism of action are inhibitors of genes, nucleic acids, and related components.
The key RoA in the Rosacea pipeline drugs market are topical, oral, injection, and inhalational. Inhalational has the highest share in the Rosacea pipeline drugs market.
The key sponsors in the Rosacea pipeline drugs market are Galderma SA, Allergan Ltd, Cutanea Life Sciences Inc, So-Gel Technologies Inc, Foamix Pharmaceuticals Ltd, Amorepacific Corp, Padagis LLC, and others.
Get in touch to find out about our multi-purchase discounts
reportstore@globaldata.com
Tel +44 (0) 20 7947 2960
Every customer’s requirement is unique. We understand that and can customize the report basis your exact research requirements pertaining to market insights, innovation insights, strategy and planning, and competitive intelligence. You can also avail the option of purchasing stand-alone sections of the report or request for a country specific report.
Testimonial
“The GlobalData platform is our go-to tool for intelligence services. GlobalData provides an easy way to access comprehensive intelligence data around multiple sectors, which essentially makes it a one-for-all intelligence platform, for tendering and approaching customers.
GlobalData is very customer orientated, with a high degree of personalised services, which benefits everyday use. The highly detailed project intelligence and forecast reports can be utilised across multiple departments and workflow scopes, from operational to strategic level, and often support strategic decisions. GlobalData Analytics and visualisation solutions has contributed positively when preparing management presentations and strategic papers.”
“COVID-19 has caused significant interference to our business and the COVID-19 intelligence from GlobalData has helped us reach better decisions around strategy. These two highlights have helped enormously to understand the projections into the future concerning our business units, we also utilise the project database to source new projects for Liebherr-Werk to use as an additional source to pitch for new business.”
Your daily news has saved me a lot of time and keeps me up-to-date with what is happening in the market, I like that you almost always have a link to the source origin. We also use your market data in our Strategic Business Process to support our business decisions. By having everything in one place on the Intelligence Center it has saved me a lot of time versus looking on different sources, the alert function also helps with this.
Having used several other market research companies, I find that GlobalData manages to provide that ‘difficult-to-get’ market data that others can’t, as well as very diverse and complete consumer surveys.
Related reports
View more Dermatology reports